Pharma

Large, worldwide pharmaceutical companies

Small molecules or biologics: that's the question

Interviewee/Contributer: Jean-Claude Muller

Organisation: Innovation and International Relationship

Full text available to subscribers only. Click here for information on subscribing to MedNous.

What lies ahead for AstraZeneca

Interviewee/Contributer: Jean-Claude Muller

Organisation: MedNous editorial board member

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Risk sharing with Pharma -- is this the way to go?

Interviewee/Contributer: Onno van de Stolpe

Organisation: Galapagos NV

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Partnering with Russia

Interviewee/Contributer: John Mayo

Organisation: Celtic Pharma Holdings

Full text available to subscribers only. Click here for information on subscribing to MedNous.

A new business model for Pharma

Interviewee/Contributer: Roel Bellens

Organisation: Strategus

Full text available to subscribers only. Click here for information on subscribing to MedNous.

As patent cliff looms Pharma looks for outside help

Interviewee/Contributer: William Ellington

Organisation: MedNous

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Why pharmacogenetics is important to Pharma

Interviewee/Contributer: Elizabeth Foot

Organisation: London Genetics Ltd

Full text available to subscribers only. Click here for information on subscribing to MedNous.

How TI Pharma leverages skills in the life sciences

Interviewee/Contributer: Willem de Laat

Organisation: TI Pharma

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Syndicate content